Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | 3.0 | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.25 | - |
NAV | ₹281.56 | - |
Fund Started | 01 Aug 2005 | - |
Fund Size | ₹1187.02 Cr | - |
Exit Load | Exit load of 1% if redeemed within 30 days. | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 43.71% | - |
3 Year | 21.05% | - |
5 Year | 27.48% | - |
1 Year
3 Year
5 Year
Equity | 98.47% | - |
Cash | 1.41% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 11.29% |
Cipla Ltd. | 5.89% |
Ajanta Pharma Ltd. | 5.38% |
Dr. Reddy's Laboratories Ltd. | 4.67% |
Gland Pharma Ltd. | 3.70% |
Glenmark Pharmaceuticals Ltd. | 3.57% |
Apollo Hospitals Enterprise Ltd. | 3.55% |
Fortis Healthcare Ltd. | 3.34% |
Procter & Gamble Health Ltd. | 3.26% |
Eris Lifesciences Ltd. | 3.07% |
Name | Kamal Gada | - |
Start Date | 02 May 2022 | - |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | - |
Launch Date | 01 Aug 2005 | - |
Description
Launch Date